Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36051 - 36075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Doxorubicin	Approved Investigational	MYC	4609	downregulated	Doxorubicin results in decreased expression of MYC mRNA	8q24.21	A20665 A21894
Doxorubicin	Approved Investigational	MYH6	4624	downregulated	Doxorubicin results in decreased expression of MYH6 mRNA	14q11.2	A21904
Doxorubicin	Approved Investigational	MYH7	4625	downregulated	Doxorubicin results in decreased expression of MYH7 mRNA	14q11.2	A21904
Doxorubicin	Approved Investigational	MYOM2	9172	downregulated	Doxorubicin results in decreased expression of MYOM2 mRNA	8p23.3	A21904
Doxorubicin	Approved Investigational	NAIP	4671	upregulated	Doxorubicin results in increased expression of NAIP mRNA	5q13.2	A22442
Doxorubicin	Approved Investigational	NDUFB7	4713	downregulated	Doxorubicin results in decreased expression of NDUFB7 mRNA	19p13.12	A22426
Doxorubicin	Approved Investigational	NEFL	4747	upregulated	Doxorubicin results in increased expression of NEFL mRNA	8p21.2	A22456
Doxorubicin	Approved Investigational	NFKB1	4790	downregulated	Doxorubicin results in decreased expression of NFKB1 mRNA	4q24	A22435
Doxorubicin	Approved Investigational	NFKB1	4790	upregulated	Doxorubicin results in increased expression of NFKB1 mRNA	4q24	A21894
Doxorubicin	Approved Investigational	NFKBIA	4792	downregulated	Doxorubicin results in decreased expression of NFKBIA mRNA	14q13.2	A22443
Doxorubicin	Approved Investigational	NLRP3	114548	upregulated	Doxorubicin results in increased expression of NLRP3 mRNA	1q44	A20449
Doxorubicin	Approved Investigational	NMBR	4829	downregulated	Doxorubicin results in decreased expression of NMBR mRNA	6q24.1	A22426
Doxorubicin	Approved Investigational	NOS2	4843	upregulated	Doxorubicin results in increased expression of NOS2 mRNA	17q11.2	A22470
Doxorubicin	Approved Investigational	NRAP	4892	downregulated	Doxorubicin results in decreased expression of NRAP mRNA	10q25.3	A21904
Doxorubicin	Approved Investigational	OR12D2	26529	upregulated	Doxorubicin results in increased expression of OR12D2 mRNA	6p22.1	A22426
Doxorubicin	Approved Investigational	OR2F1	26211	downregulated	Doxorubicin results in decreased expression of OR2F1 mRNA	7q35	A22426
Doxorubicin	Approved Investigational	P2RX2	22953	upregulated	Doxorubicin results in increased expression of P2RX2 mRNA	12q24.33	A22426
Doxorubicin	Approved Investigational	PAX6	5080	upregulated	Doxorubicin results in increased expression of PAX6 mRNA	11p13	A22426
Doxorubicin	Approved Investigational	PGR	5241	upregulated	Doxorubicin results in increased expression of PGR mRNA	11q22.1	A22452
Doxorubicin	Approved Investigational	PITX1	5307	upregulated	Doxorubicin results in increased expression of PITX1 mRNA	5q31.1	A22426
Doxorubicin	Approved Investigational	PLAU	5328	upregulated	Doxorubicin results in increased expression of PLAU mRNA	10q22.2	A22471
Doxorubicin	Approved Investigational	PLK1	5347	downregulated	Doxorubicin results in decreased expression of PLK1 mRNA	16p12.2	A22430
Doxorubicin	Approved Investigational	PMAIP1	5366	upregulated	Doxorubicin results in increased expression of PMAIP1 mRNA	18q21.32	A22451
Doxorubicin	Approved Investigational	POLD4	57804	upregulated	Doxorubicin results in increased expression of POLD4 mRNA	11q13.2	A22426
Doxorubicin	Approved Investigational	POMT2	29954	upregulated	Doxorubicin results in increased expression of POMT2 mRNA	14q24.3	A22426

Displaying entries 36051 - 36075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability